CRISPR-mediated Correction of Oncogenic AS-NMD in Splicing Factor Mutant Cancer
Preeti Nagar, Md Rafikul Islam, Nirjhor Anuvob Rahman, Shabiha Afroj Heeamoni, Md Mahbub Hasan, Saaimatul Huq, Rezwan Ali, Mokarram Hossain, Mohammad Alinoor Rahman
This paper demonstrates CRISPR-mediated correction of oncogenic AS-NMD in splicing factor mutant cancer by deleting a poison exon from the tumor suppressor EZH2.
bioRxiv · Jul 29, 2026 · PreprintCancer Biology